Pell Bio-Med Technology Co., Ltd. (TPE:6949)
Taiwan · Delayed Price · Currency is TWD 958.00
+84.00 (9.61%)
Aug 5, 2026, 1:30 PM CST
Pell Bio-Med Technology Market Cap
Pell Bio-Med Technology has a market cap or net worth of 62.07 billion as of August 5, 2026. Its market cap has increased by 356.54% in one year.
Market Cap
62.07B
Enterprise Value
60.22B
Revenue
25.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
958.00
ChartMarket Cap Chart
Since March 8, 2024, Pell Bio-Med Technology's market cap has increased from 5.56B to 62.07B, an increase of 1,017.17%. That is a compound annual growth rate of 172.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2026 | 62.07B | 209.40% |
| Dec 31, 2025 | 20.06B | 324.81% |
| Dec 31, 2024 | 4.72B | -15.00% |
| Mar 8, 2024 | 5.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 170.42B |
| Lin BioScience | 57.65B |
| CHO Pharma | 25.25B |
| Oneness Biotech | 21.79B |
| Sunmax Biotechnology | 20.86B |
| TaiMed Biologics | 15.55B |
| Medigen Vaccine Biologics | 15.40B |
| Ever Supreme Bio Technology | 14.91B |